FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
about
FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Analysis of the clinical significance of DCLK1 colorectal cancer using novel monoclonal antibodies against DCLK1
P2860
FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
FOXD3 Regulates CSC Marker, DC ...... Implications in Colon Cancer.
@en
type
label
FOXD3 Regulates CSC Marker, DC ...... Implications in Colon Cancer.
@en
prefLabel
FOXD3 Regulates CSC Marker, DC ...... Implications in Colon Cancer.
@en
P2093
P2860
P1476
FOXD3 Regulates CSC Marker, DC ...... Implications in Colon Cancer.
@en
P2093
Brian S Lee
Malaney R O'Connell
Masato Kusunoki
Pomila Singh
Robert D Daboval
Shubhashish Sarkar
Yoshinaga Okugawa
Yuji Toiyama
P2860
P304
P356
10.1158/1541-7786.MCR-17-0287
P50
P577
2017-08-29T00:00:00Z